๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Prostate-specific membrane antigen: present and future applications

โœ Scribed by Sam S Chang; Paul B Gaudin; Victor E Reuter; Warren D.W Heston


Book ID
117266423
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
694 KB
Volume
55
Category
Article
ISSN
0090-4295

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Prostate-specific membrane antigen
โœ Fair, William R.; Israeli, Ron S.; Heston, Warren D.W. ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 545 KB

## Background: In an effort to discover new prostate-specific antigens (psas) to enhance our understanding of the functions and behavior of the prostate and the complex processes involved in prostate tumor progression, the structure and function of the psm antigen has been elucidated. ## Methods:

Prostate-specific membrane antigen (PSMA
โœ Abdel-Aziz A. Elgamal; Eric H. Holmes; Sai L. Su; William T. Tino; Sheila J. Sim ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 49 KB ๐Ÿ‘ 2 views

We will review the evolution, benefits, and limitations of PSMA testing in the past, as well as its current and future value. Prostate cancer has been the most frequently diagnosed cancer and the second leading cause of cancer death in men in the United States. It has a wide spectrum of biological b

Comparison of serum prostate specific me
โœ Thomas H. Douglas; Ted O. Morgan; David G. McLeod; Judd W. Moul; Gerald P. Murph ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 92 KB ๐Ÿ‘ 1 views

ated with higher pathologic stage and grade in patients undergoing radical prostatectomy (RP). In earlier studies, serum prostate specific membrane antigen (PSMA)

Evaluation and comparison of two new pro
โœ Gerald P. Murphy; Robert J. Barren; Sheila J. Erickson; Victoria A. Bowes; Rober ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 816 KB

## BACKGROUND. Two new prostate cancer markers, free-prostate specific antigen (f-PSA) and prostate specific membrane antigen (PSMA) were recently introduced. This report summarizes a prospective two-year multicenter test of their diagnostic or prognostic capabilities. Total PSA was also measured.